Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Eisai receives marketing authorization in Japan for vascular embolization device Dc Bead

April 18, 2013

Bayer prepares new Mnk1 inhibitors for hyperproliferative diseases

April 18, 2013

Roche discloses novel eIF4E inhibitors for cancer

April 18, 2013

VAL-201 shows promise in animal models of prostate and breast cancer

April 18, 2013

Bayer Intellectual Property discloses new anticancer agents

April 17, 2013

First-in-human results for ARQ-092 demonstrate disease stabilization in patients with solid tumors

April 17, 2013

NT-113, a pan-erbB inhibitor active against brain metastases in rodents

April 17, 2013

Merrimack updates progress of phase II HER2-negative breast cancer study

April 16, 2013

Board recommends continuation of enobosarm phase III trials

April 16, 2013

Phase I study of Mologen's MGN-1404 approved by Paul-Ehrlich Institute

April 16, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...